Caris Life Sciences, Inc. (CAI)

NMS – Real Time Price. Currency in USD

22.15

-0.99 (-4.30%)

Market open: Aug 12, 2026, 3:10 PM EDT

22.87

-0.27 (-1.17%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

Total Revenue

812M

412M

306M

Cost of goods sold

-273M

-233M

-217M

Gross Profit

539M

179M

89M

Operating expenses (excl. COGS)

-494M

-436M

-409M

Operating Income

45M

-257M

-320M

Non-operating income, total

-113M

-25M

-22M

Pretax income

-68M

-282M

-341M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-68M

-282M

-341M

Discontinued operations

Net income

-68M

-282M

-341M

Dilution adjustment

Preferred dividends

470M

96M

121M

Caris Life Sciences, Inc. (CAI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Caris Life Sciences, Inc. (CAI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Caris Life Sciences, Inc. (CAI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Caris Life Sciences, Inc. (CAI)

Income Statement (Annual)

Income Statement (Annual)